Prevalence and risk factors of leukocytosis among heart failure patients

Author(s):  
Ajaz Ahmad ◽  
Majid Alharbi ◽  
Omar Aldhabaan ◽  
Yazid Alzapni ◽  
Sultan Alanazi ◽  
...  
Author(s):  
Md Sheikh ◽  
Manahel Alotaibi ◽  
Nouf Almutairi ◽  
Eid Aljohani ◽  
Omar Alruwaili ◽  
...  

Author(s):  
Naila Niaz ◽  
Syed Muhammad Faraz Ali ◽  
Attaullah Younas ◽  
Tallat Anwar Faridi ◽  
Asif Hanif

Despite advancing medical technology, Heart Failure (HF) is still a prevalent disease with high mortality and high health expenditure. To improve patient outcome and prognosis, it is important to identify the association of risk factors which leads to the co-morbid depression and anxiety in heart failure patients. Objectives: To determine the association of depression and/or anxiety with age, gender and ejection fraction in heart failure patients. Methods: It is an analytical cross sectional study including 323 CHF patients who visited the to the Faisalabad Institute of Cardiology hospital Out-Patient Department, 250 were males and 73 were females, mean age was 54.1 ± 9.2 years having 70 years as maximum and 25 years as minimum.  Data collection was done using Hospital Anxiety and Depression Scale (HADS) questionnaire to assess depression and anxiety. Data was analyzed using SPSS version 24. For quantitative data, mean and standard deviation was calculated and for qualitative data frequency and percentages was calculated. To measure the association of anxiety and depression with age categories, ejection fraction and gender, chi square test was used. P values less than and equal to 0.05 were taken as significant. Results: No association of depression and anxiety with gender and Left Ventricular Ejection Fraction (LVEF) was observed. However, depression and anxiety were found to be significantly associated with age Conclusions: The study concluded that age is a strong risk factor of depression and anxiety in congestive heart failure patients. Multidisciplinary health care team approach and interventions are required to cater chronic heart failure (CHF) patients to address the psychological burden.


2019 ◽  
Vol 35 (9) ◽  
pp. 1097-1105 ◽  
Author(s):  
Stephen J. Greene ◽  
G. Michael Felker ◽  
Anna Giczewska ◽  
Andreas P. Kalogeropoulos ◽  
Andrew P. Ambrosy ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Michael G. Alexandrakis ◽  
George Tsirakis

Heart failure is a very common disease, with severe morbidity and mortality, and a frequent reason of hospitalization. Anemia and a concurrent renal impairment are two major risk factors contributing to the severity of the outcome and consist of the cardio renal anemia syndrome. Anemia in heart failure is complex and multifactorial. Hemodilution, absolute or functional iron deficiency, activation of the inflammatory cascade, and impaired erythropoietin production and activity are some pathophysiological mechanisms involved in anemia of the heart failure. Furthermore other concomitant causes of anemia, such as myelodysplastic syndrome and chemotherapy, may worsen the outcome. Based on the pathophysiology of cardiac anemia, there are several therapeutic options that may improve hemoglobin levels, tissues’ oxygenation, and probably the outcome. These include administration of iron, erythropoiesis-stimulating agents, and blood transfusions but still the evidence provided for their use remains limited.


2015 ◽  
Vol 26 (8) ◽  
pp. 599-602 ◽  
Author(s):  
Tamiharu Yamagishi ◽  
Kenichi Matsushita ◽  
Toshinori Minamishima ◽  
Ayumi Goda ◽  
Konomi Sakata ◽  
...  

2009 ◽  
Vol 137 (1) ◽  
pp. 47-53 ◽  
Author(s):  
Roberta Poletti ◽  
Claudio Passino ◽  
Alberto Giannoni ◽  
Luc Zyw ◽  
Concetta Prontera ◽  
...  

2016 ◽  
Vol 34 (1) ◽  
pp. 103-108 ◽  
Author(s):  
Preethy Nayar ◽  
Fang Yu ◽  
Aastha Chandak ◽  
Ge Lin Kan ◽  
Brian Lowes ◽  
...  

2018 ◽  
Vol 75 (11) ◽  
pp. 1083-1088
Author(s):  
Marko Lazovic ◽  
Sonja Radenkovic ◽  
Dijana Stojanovic ◽  
Jelena Radovic ◽  
Miodrag Stojanovic ◽  
...  

Background/Aim. A predictor of a poor prognosis, renal dysfunction often manifests in patients with heart failure, and is associated with an increased mortality in these patients. The aim of the parent study was to determine risk factors associated with worsening renal function (WRF) in patients hospitalized for acutely decompensated heart failure. Methods. The study included 330 patients with acutely decompensated heart failure. Patients who developed WRF (n = 215, mean age 72.4 ? 9.8 years) were in the clinical group, and patients without WRF (n = 115, mean age 59.8 ? 11.7 years) were in the control group. Patients in the clinical group were observed according to: the age, gender, lipids, electrolytes, smoking, hypertension, and type of heart failure, with reduced or preserved left ventricle ejection fraction (HFrEF or HFpEF). We used logistic regression to calculate non-adjusted odds ratio (OR) and 95% confidence intervals for occurrence of WRF. Results. WRF was determined in 65.2% of patients with heart failure. Non-adjusted OR showed that there was a significant risk for development of WRF with age (OR = 4.3; p < 0.01), total cholesterol > 5.2 mmol/L (OR = 1.6; p < 0.05), hyponatremia < 135 mmol/L, (OR = 2.8; p < 0.01), smoking (OR = 3.9; p < 0.01), hypertension (OR = 2.0; p < 0.05), and with the presence of HFrEF (OR = 1.3; p < 0.01). Presence of HFpEF, hypokalemia, < 3.5 mmol/L, plasma triglycerides, > 1.7 mmol/L, and gender, did not have any significance for the development of renal damage. Conclusion. Patients? age, total cholesterol, hyponatremia, smoking, hypertension, and HFrEF were significant risk factors for worsening renal function in heart failure patients. Comparing predictive values, age could be the best prognostic tool for early identification of patients at risk for WRF.


Sign in / Sign up

Export Citation Format

Share Document